Barriers and facilitators to insulin treatment: a phenomenological inquiry
Background Despite being the most effective treatment for advanced type 2 diabetes, the choice to start and maintain insulin therapy is based on a variety of criteria, including the patients’ acceptance and willingness to adhere to it. The patients’ beliefs and experiences, on the other hand, could...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-12-01
|
| Series: | Journal of Pharmaceutical Policy and Practice |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1186/s40545-022-00441-z |
| _version_ | 1797401270908092416 |
|---|---|
| author | Ewunetie Mekashaw Bayked Mesfin Haile Kahissay Birhanu Demeke Workneh |
| author_facet | Ewunetie Mekashaw Bayked Mesfin Haile Kahissay Birhanu Demeke Workneh |
| author_sort | Ewunetie Mekashaw Bayked |
| collection | DOAJ |
| description | Background Despite being the most effective treatment for advanced type 2 diabetes, the choice to start and maintain insulin therapy is based on a variety of criteria, including the patients’ acceptance and willingness to adhere to it. The patients’ beliefs and experiences, on the other hand, could not be revealed without a thorough exploration. Objectives This study investigated the barriers and facilitators to insulin treatment from the perspectives of patients with type 2 diabetes following treatment at Dessie Comprehensive Specialized Hospital, North-East Ethiopia. Methods A phenomenological study was conducted from July 2019 to January 2020. Twenty-four (11 males and 13 females) participants were recruited purposively. Data were collected through face-to-face in-depth interviews, lasted about 23 to 71 min, until theoretical saturation was reached, and then organized using QDA Miner Lite v2.0.9. The transcripts were thematically analyzed using narrative strategies and the themes that arose were discussed in detail. Results The most common facilitator of insulin treatment was its relative effectiveness, which was followed by its convenience (fewer gastrointestinal side effects, small needle size and ease of use), the concept of it is life, faith in doctors’ decisions, family support, and health insurance membership. The most common impediments, on the other hand, were market failures (expensiveness and supply shortages), followed by its properties and patients’ circumstances. Conclusions Market failures due to supply shortages and associated costs were identified to be the most significant barriers to insulin treatment, necessitating the availability of an effective pharmaceutical supply management strategy that targets on insulin supply and affordability. It is also strongly recommended that health insurance coverage be increased. |
| first_indexed | 2024-03-09T02:07:32Z |
| format | Article |
| id | doaj.art-4996b81d78f546249cb70aa958206827 |
| institution | Directory Open Access Journal |
| issn | 2052-3211 |
| language | English |
| last_indexed | 2024-03-09T02:07:32Z |
| publishDate | 2022-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Journal of Pharmaceutical Policy and Practice |
| spelling | doaj.art-4996b81d78f546249cb70aa9582068272023-12-07T15:28:04ZengTaylor & Francis GroupJournal of Pharmaceutical Policy and Practice2052-32112022-12-0115110.1186/s40545-022-00441-z12315351Barriers and facilitators to insulin treatment: a phenomenological inquiryEwunetie Mekashaw Bayked0Mesfin Haile Kahissay1Birhanu Demeke Workneh2Department of Pharmacy, College of Medicine and Health Sciences (CMHS),Department of Pharmaceutics and Social Pharmacy, School of Pharmacy,Department of Pharmacy, College of Medicine and Health Sciences (CMHS),Background Despite being the most effective treatment for advanced type 2 diabetes, the choice to start and maintain insulin therapy is based on a variety of criteria, including the patients’ acceptance and willingness to adhere to it. The patients’ beliefs and experiences, on the other hand, could not be revealed without a thorough exploration. Objectives This study investigated the barriers and facilitators to insulin treatment from the perspectives of patients with type 2 diabetes following treatment at Dessie Comprehensive Specialized Hospital, North-East Ethiopia. Methods A phenomenological study was conducted from July 2019 to January 2020. Twenty-four (11 males and 13 females) participants were recruited purposively. Data were collected through face-to-face in-depth interviews, lasted about 23 to 71 min, until theoretical saturation was reached, and then organized using QDA Miner Lite v2.0.9. The transcripts were thematically analyzed using narrative strategies and the themes that arose were discussed in detail. Results The most common facilitator of insulin treatment was its relative effectiveness, which was followed by its convenience (fewer gastrointestinal side effects, small needle size and ease of use), the concept of it is life, faith in doctors’ decisions, family support, and health insurance membership. The most common impediments, on the other hand, were market failures (expensiveness and supply shortages), followed by its properties and patients’ circumstances. Conclusions Market failures due to supply shortages and associated costs were identified to be the most significant barriers to insulin treatment, necessitating the availability of an effective pharmaceutical supply management strategy that targets on insulin supply and affordability. It is also strongly recommended that health insurance coverage be increased.http://dx.doi.org/10.1186/s40545-022-00441-ztype 2 diabetesinsulinbarriersfacilitatorsphenomenologyethiopia |
| spellingShingle | Ewunetie Mekashaw Bayked Mesfin Haile Kahissay Birhanu Demeke Workneh Barriers and facilitators to insulin treatment: a phenomenological inquiry Journal of Pharmaceutical Policy and Practice type 2 diabetes insulin barriers facilitators phenomenology ethiopia |
| title | Barriers and facilitators to insulin treatment: a phenomenological inquiry |
| title_full | Barriers and facilitators to insulin treatment: a phenomenological inquiry |
| title_fullStr | Barriers and facilitators to insulin treatment: a phenomenological inquiry |
| title_full_unstemmed | Barriers and facilitators to insulin treatment: a phenomenological inquiry |
| title_short | Barriers and facilitators to insulin treatment: a phenomenological inquiry |
| title_sort | barriers and facilitators to insulin treatment a phenomenological inquiry |
| topic | type 2 diabetes insulin barriers facilitators phenomenology ethiopia |
| url | http://dx.doi.org/10.1186/s40545-022-00441-z |
| work_keys_str_mv | AT ewunetiemekashawbayked barriersandfacilitatorstoinsulintreatmentaphenomenologicalinquiry AT mesfinhailekahissay barriersandfacilitatorstoinsulintreatmentaphenomenologicalinquiry AT birhanudemekeworkneh barriersandfacilitatorstoinsulintreatmentaphenomenologicalinquiry |